FindTrial
Sign In

Clinical Study on Non proliferative Diabetic retinopathy

An open Clinical Controlled study of Mahagiwati o KAPHAPITTA VIDAGDHA DRISHTI with special rference to BACKGROUND (NON PROLIFERATIVE ) DIABETIC RETIOPATHY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/04/006797
Enrollment
30
Registered
2016-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Non proliferative diabetic retinopathy Health Condition 2: E113- Type 2 diabetes mellitus with ophthalmic complications

Interventions

Intervention1: Mahagniwati: prepared from ghana of medicinal plants(Cyperus rotundus,Terminalia chebula,Emblica officinalis,Tionspora cordifolia,Azadirecta indica. 500 mg BD. Orally. Till Six months

Sponsors

RAPODAR AYU MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Age between 30-70 year with H/0 Type 2DM for at least 2 years or more than that. 2)Well controlled Type 2 DM (on OHA as advised by Physician) 3)HbA1C 7-8 mmol/lit Fasting BSL up to 150 mg/dl , PM â??up to 250 mg/dl) Shows signs and symptoms of NPDR.

Exclusion criteria

Exclusion criteria: 1)Proliferative Diabetic Retinopathy 2)Blood Pressure >140/90 mm Hg. (may/may not be on antihypertensive) 3)Glaucoma 4)Cataract 5)Uncontrolled Type 2 DM (fasting >150mg/dl; PM >250 mg/dl; HbA1C > 8)

Design outcomes

Primary

MeasureTime frame
Blood sugar level lipid profile liver and kidney functions HbA1C Intraocular pressureTimepoint: Blood sugar level(Every month) lipid profile(After 6 months) liver and kidney functions(After 6 months HbA1C(After 6 months Intraocular pressure—

Secondary

MeasureTime frame
effect on bsl,lipid,Hba1C, RFT ,LFTTimepoint: 6 Months—

Countries

India

Contacts

Public ContactDr Hema Kolpe

R.A.Podar ayurved Medical College

dramrut16@gmail.com9819139017

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 16, 2026